Skip to contents

Saussele, Susanne; Stein, Mareike; Gil, Arthur; Kossak-Roth, Ute; Lauseker, Michael; Proetel, Ulrike; Einsele, Hermann; Schafhausen, Philippe; Lange, Elisabeth; Hänel, Mathias; Spiekermann, Karsten; Sökler, Martin; Wendtner, Clemens; Kremers, Stephan; Pfreundschuh, Michael; Holler, Ernst; Hofmann, Wolf-Karsten; Hochhaus, Andreas; Müller, Martin C.; Hehlmann, Ruediger; Pfirrmann, Markus

Health-Related Quality of Life Impairment in Patients with Chronic Myeloid Leukemia: Results of a German Cross-Sectional Study of Patients Registered in Prospective, Controlled Clinical Trials

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2015

Published in: Blood
Engert, Andreas; Plütschow, Annette; Eich, Hans Theodor; Lohri, Andreas; Dörken, Bernd; Borchmann, Peter; Berger, Bernhard; Greil, Richard; Willborn, Kay C.; Wilhelm, Martin; Debus, Jürgen; Eble, Michael J.; Sökler, Martin; Ho, Antony; Rank, Andreas; Ganser, Arnold; Trümper, Lorenz; Bokemeyer, Carsten; Kirchner, Hartmut; Schubert, Jörg; Král, Zdenek; Fuchs, Michael; Müller-Hermelink, Hans-Konrad; Müller, Rolf-Peter;

Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

Massachusetts Medical Society, 2010

Published in: New England Journal of Medicine
Bröckelmann, Paul J; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Trautmann, Karolin; Halbsguth, Teresa V; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas

Efficacy and Safety of Nivolumab and AVD in Early-Stage Unfavorable Hodgkin Lymphoma: Extended Follow-up from the GHSG Phase II Nivahl Trial

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2020

Published in: Blood
Bröckelmann, Paul J; Goergen, Helen; Keller, Ulrich; Meissner, Julia; Ordemann, Rainer; Halbsguth, Teresa V; Sasse, Stephanie; Sökler, Martin; Kerkhoff, Andrea; Mathas, Stephan; Hüttmann, Andreas; Bormann, Matthias; Zimmermann, Andreas; Fuchs, Michael; von Tresckow, Bastian; Baues, Christian; Rosenwald, Andreas; Klapper, Wolfram; Kobe, Carsten; Borchmann, Peter; Engert, Andreas

Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2019

Published in: Blood
Borchmann, Peter; Goergen, Helen; Kobe, Carsten; Lohri, Andreas; Greil, Richard; Eichenauer, Dennis A.; Zijlstra, Josée M; Markova, Jana; Meissner, Julia; Feuring-Buske, Michaela; Hüttmann, Andreas; Dierlamm, Judith; Sökler, Martin; Krause, Stefan W.; Eich, Hans; Baues, Christian; Kreissl, Stefanie; Fuchs, Michael; Dietlein, Markus; Engert, Andreas

Early Interim PET in Patients with Advanced-Stage Hodgkin's Lymphoma Treated within the Phase 3 GHSG HD18 Study

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2017

Published in: Blood
Eichhorst, Barbara F.; Bahlo, Jasmin; Maurer, Christian; Lange, Elisabeth; Köppler, Hubert; Kiehl, Michael G; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Herling, Marco; Fischer, Kirsten; Döhner, Hartmut; Kneba, Michael; Wendtner, Clemens; Klapper, Wolfram; Kreuzer, Karl-Anton; Böttcher, Sebastian; Stilgenbauer, Stephan; Fink, Anna Maria; Hallek, Michael

Favorable Toxicity Profile and Long Term Outcome of Elderly, but Physically Fit CLL Patients (pts) Receiving First Line Bendamustine and Rituximab (BR) Frontline Chemoimmunotherapy in Comparison to Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Advanced Chronic Lymphocytic Leukemia (CLL): Update Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2016

Published in: Blood
Stilgenbauer, Stephan; Cymbalista, Florence; Leblond, Véronique; Delmer, Alain; Ibach, Stefan; Choquet, Sylvain; Dartigeas, Caroline; Cazin, Bruno; Tournilhac, Olivier; Pegourie, Brigitte; Seiler, Till M; Sökler, Martin; Zirlik, Katja; Alt, Jürgen; Huber, Henriette; Bloehdorn, Johannes; Tausch, Eugen; Zenz, Thorsten; Hallek, Michael; Schetelig, Johannes; Dreger, Peter; Döhner, Hartmut

Alemtuzumab Combined with Dexamethasone, Followed By Alemtuzumab Maintenance or Allo-SCT in “ultra High-risk” CLL: Final Results from the CLL2O Phase II Study

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2014

Published in: Blood
Eichhorst, Barbara; Fink, Anna-Maria; Busch, Raymonde; Lange, Elisabeth; Köppler, Hubert; Kiehl, Michael; Sökler, Martin; Schlag, Rudolf; Vehling-Kaiser, Ursula; Köchling, Georg; Plöger, Christoph; Gregor, Michael; Plesner, Torben; Trneny, Marek; Fischer, Kirsten; Döhner, Hartmut; Kneba, Michael; Wendtner, Clemens; Klapper, Wolfram; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Böttcher, Sebastian; Hallek, Michael

Chemoimmunotherapy With Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Bendamustine and Rituximab (BR) In Previously Untreated and Physically Fit Patients (pts) With Advanced Chronic Lymphocytic Leukemia (CLL): Results Of a Planned Interim Analysis Of The CLL10 Trial, An International, Randomized Study Of The German CLL Study Group (GCLLSG)

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2013

Published in: Blood
Stilgenbauer, Stephan; Cymbalista, Florence; Leblond, Veronique; Delmer, Alain; Mack, Silja; Bühler, Andreas; Winkler, Dirk; Zenz, Thorsten; Busch, Raymonde; Ibach, Stefan; Choquet, Sylvain; Caroline, Dartigeas; Cazin, Bruno; Tournilhac, Olivier; Seiler, Till M; Zirlik, Katja; Alt, Jürgen; Sökler, Martin; Schetelig, Johannes; Dreger, Peter; Hallek, Michael; Döhner, Hartmut

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Updated Results From a Phase II Study of the Gcllsg and fcgcll/MW

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2012

Published in: Blood
Stilgenbauer, Stephan; Cymbalista, Florence; Leblond, Véronique; Delmer, Alain; Winkler, Dirk; Bühler, Andreas; Zenz, Thorsten; Mack, Silja; Busch, Raymonde; Hinke, Axel; Choquet, Sylvain; Dartigeas, Caroline; Cazin, Bruno; Tournilhac, Olivier; Rieger, Michael; Alt, Jürgen; Sökler, Martin; Schetelig, Johannes; Dreger, Peter; Hallek, Michael; Döhner, Hartmut

Alemtuzumab Plus Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allogeneic Transplantation in Ultra High-Risk CLL: Interim Analysis of a Phase II Study of the GCLLSG and fcgcll/MW

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2011

Published in: Blood
Stilgenbauer, Stephan; Cymbalista, Florence; Leblond, Véronique; Delmer, Alain; Zenz, Thorsten; Winkler, Dirk; Bühler, Andreas; Mack, Silja; Busch, Raymonde; Ibach, Stefan; Choquet, Sylvain; Dartigeas, Caroline; Cazin, Bruno; Tournilhac, Olivier; Rieger, Michael; Sökler, Martin; Seiler, Till; Schetelig, Johannes; Dreger, Peter; Hallek, Michael; Döhner, Hartmut

Subcutaneous Alemtuzumab Combined with Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT In CLL with 17p- or Refractory to Fludarabine – Interim Analysis of the CLL2O Trial of the GCLLSG and FCGCLL/MW

View online
Schließen

Access

Close

Bookmarks

You can manage bookmarks using lists, please log in to your user account for this.

American Society of Hematology, 2010

Published in: Blood

You did not find what you were looking for?

Purchase suggestion
Are you missing something you need for your research? If you have any suggestions please share them here.

Interlibrary Loan
Please search and order your favorite title in the Interlibrary Loan Portal.

Search in field:

Recently searched for:

You did not find what you were looking for?

> Year of publication

Year of publication